|
SpringWorks Therapeutics, Inc.
|
3,481,148
|
$165,946,000
|
2.42%
|
-33,210
|
+$18,343,000
|
|
MyoKardia, Inc.
|
1,395,017
|
$190,183,000
|
2.78%
|
No Change
|
+$55,396,000
|
|
Zymeworks Inc.
|
4,400,999
|
$204,999,000
|
2.99%
|
+820,000
|
+$75,833,000
|
|
CYTOKINETICS INC
NOTE 4.000%11/1
|
9,770,000
|
$218,301,000
|
3.19%
|
-230,000
|
-$19,959,000
|
|
BridgeBio Pharma, Inc.
|
6,706,268
|
$251,619,000
|
3.67%
|
No Change
|
+$32,928,000
|
|
Global Blood Therapeutics, Inc.
|
5,800,996
|
$319,867,000
|
4.67%
|
-41,104
|
-$48,944,000
|
|
IOVANCE BIOTHERAPEUTICS, INC.
|
10,085,632
|
$332,019,000
|
4.85%
|
-1,723,862
|
+$7,849,000
|
|
AMICUS THERAPEUTICS, INC.
|
25,122,048
|
$354,723,000
|
5.18%
|
-60,316
|
-$25,027,000
|
|
Retrophin, Inc.
NOTE 2.500% 9/1
|
45,000,000
|
$390,119,000
|
5.70%
|
No Change
|
+$40,140,000
|
|
Mirati Therapeutics, Inc.
|
3,435,575
|
$570,477,000
|
8.33%
|
+664,525
|
+$254,106,000
|